Use of IL-15 After Chemotherapy and Lymphocyte Transfer in Metastatic Melanoma
Condition(s):Metastatic Melanoma; Skin CancerLast Updated:January 27, 2015Terminated
Hide Studies Not Open or Pending
Condition(s):Metastatic Melanoma; Skin CancerLast Updated:January 27, 2015Terminated
Condition(s):Metastatic CancersLast Updated:July 3, 2023Completed
Condition(s):Melanoma; Metastatic MelanomaLast Updated:August 20, 2020Withdrawn
Condition(s):Metastatic Melanoma; Head and Neck Squamous Cell CarcinomaLast Updated:March 28, 2024Recruiting
Condition(s):Metastatic MelanomaLast Updated:September 6, 2022Recruiting
Condition(s):Metastatic MelanomaLast Updated:January 12, 2022Completed
Condition(s):Metastatic MelanomaLast Updated:April 5, 2013Withdrawn
Condition(s):Metastatic MelanomaLast Updated:December 11, 2015Withdrawn
Condition(s):Metastatic MelanomaLast Updated:July 14, 2011Completed
Condition(s):Metastatic MelanomaLast Updated:March 1, 2023Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.